- Telehealth Visits
- Insurance plan information
Mary G. De May, MD
Psychiatry • Geriatric Psychiatry- Telehealth Visits
- Insurance plan information
Mary G. De May, MD
Psychiatry • Geriatric Psychiatry- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Mary De May is a geriatric psychiatrist who evaluates new patients and research participants, in addition to caring for patients already diagnosed with neurodegenerative diseases. She also performs psychiatric evaluations for patients referred from within the Memory and Aging Center, and helps them find appropriate psychiatric care in the community as needed.
De May earned her medical degree at Stony Brook University. She completed a psychiatry residency and fellowship at the University of Pittsburgh Medical Center Western Psychiatric Hospital.
At UCSF, De May teaches residents and fellows in neurology, psychiatry interns, fellows in geriatric medicine and other health care professionals.
Education & training
Board certification
- Geriatric Psychiatry, American Board of Psychiatry and Neurology
- Psychiatry, American Board of Psychiatry and Neurology
Fellowship
- Geriatric Psychiatry, University of Pittsburgh Medical Center
Residency
- Psychiatry, University of Pittsburgh Medical Center
Internship
- Hospital of the University of Pennsylvania
Degree
- MD, State University of New York at Stony Brook
My expertise
Specialties
- Psychiatry
- Geriatric Psychiatry
Conditions
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22798%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22798%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.